臺灣博碩士論文加值系統

Ketoconazole這個廣效性的抗黴菌藥物，是臨床上時常被使用的口服抗黴菌藥，其可抑制睪丸及腎上腺的類脂醇生成，因此Ketoconazole被用於治療人體某些依賴荷爾蒙生長的癌症上。藉由細胞生長曲線的分析，我們觀察到Ketoconazole可抑制前列腺癌細胞生長停滯，本研究證實Ketoconazole能抑制前列腺癌細胞的生長。此外在LNCaP睪固酮依賴性前列腺癌細胞(androgen-dependent prostate cancer cell)，由DNA膠體電泳可觀察到DNA呈現由大至小分子量的階梯狀，顯示Ketoconazole會造成LNCaP細胞的凋亡。此外，從蛋白的表現我們發現Ketoconazole會引起前列腺癌細胞株p53蛋白表現量增加，且活化Bax等蛋白的表現，而且Ketoconazole會經由活化caspases誘發細胞凋亡的發生。雖然細胞凋亡的發生並未在PC-3睪固酮依賴性前列腺癌細胞(androgen-independent prostate cancer cell)中觀察到，但是仍可看見p53與Bax蛋白的表現量因Ketoconazole的刺激而增加。由以上結果，我們推測Ketoconazole抑制人類睪固酮依賴性前列腺癌細胞的生長可能是因誘發了前列腺癌細胞凋亡的分子機制所造成，而引發此機制的訊息傳遞可能與睪固酮受體(androgen receptor)的存在與否有關。

In this study, we demonstrated that Ketoconazole (KT), a widely used oral-antifungal agents, can inhibit androgen-dependent prostate cancer cell (LNCaP) and androgen-independent prostate cancer cell (PC-3) proliferation ,KT also induce apoptosis in LNCaP cell. In this study, we used androgen-dependent and androgen-independent prostate cancer cell line to investigate the mechanisms of Ketoconazole-induced apoptosis. In androgen-dependent prostate cancer cell, DNA fragmentation analysis revealed that apoptosis was induced in a dose dependent manner by Ketoconazole treatment. The caspase 3 was activated and its specific substrate, poly（ADP-ribose）polymerase, was degraded at 18-24 h after Ketoconazole treatment. But these results did not find in androgen-independent prostate cancer cell. Dose-dependent experiment was performed and demonstrated that the p53 and Bax gene expression was elevated both in these two cells. Taken together, these results suggest that KT in cessation of androgen-dependent prostate cancer cell proliferation, that may cause by the induction of apoptosis and this induction of apoptosis may relate to the existence of androgen receptor.

中文摘要……………………………………..1
(Abstract in Chinese)
英文摘要……………………………………..2
(Abstract in English)
序論…………………………………………..3-11
(Introduction)
實驗材料和方法……………………………..12-24
(Materials and Methods)
結果…………………………………………..25-35
(Results)
討論…………………………………………..36-38
(Discussion)
參考文獻……………………………………..39-48
(References)

Abraham, J., Kelly, J., Thibault, P. and Benchimol, S. (2000) Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry. Journal of Molecular Biology, 295, 853-64.
Alvarez-Gonzalez, R. and Jacobson, M.K. (1987) Characterization of polymers of adenosine diphosphate ribose generated in vitro and in vivo. Biochemistry, 26, 3218-24.
Blagosklonny, M.V., Dixon, S.C. and Figg, W.D. (2000) Efficacy of microtubule-active drugs followed by ketoconazole in human metastatic prostate cancer cell lines. Journal of Urology, 163, 1022-6.
Dasika, G.K., Lin, S.C., Zhao, S., Sung, P., Tomkinson, A. and Lee, E.Y. (1999) DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene, 18, 7883-99.
Dixon, S.C., Zalles, A., Giordano, C., Lush, R.M., Venzon, D., Reed, E. and Figg, W.D. (1997) In vitro effect of gallium nitrate when combined with ketoconazole in the prostate cancer cell line PC-3. Cancer Letters, 113, 111-6.
Eichenberger, T., Trachtenberg, J., Toor, P. and Keating, A. (1989) Ketoconazole: a possible direct cytotoxic effect on prostate carcinoma cells. Journal of Urology, 141, 190-1.
Gibbons, N.B., Watson, R.W., Coffey, R.N., Brady, H.P. and Fitzpatrick, J.M. (2000) Heat-shock proteins inhibit induction of prostate cancer cell apoptosis. Prostate, 45, 58-65.
Gold, R., Schmied, M., Rothe, G., Zischler, H., Breitschopf, H., Wekerle, H. and Lassmann, H. (1993) Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. Journal of Histochemistry & Cytochemistry, 41, 1023-30.
Gu, Y., Sarnecki, C., Aldape, R.A., Livingston, D.J. and Su, M.S. (1995) Cleavage of poly(ADP-ribose) polymerase by interleukin-1 beta converting enzyme and its homologs TX and Nedd-2. Journal of Biological Chemistry, 270, 18715-8.
Guo, C., Luttrell, L.M. and Price, D.T. (2000) Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines. Journal of Urology, 163, 1027-32.
Haffner, R. and Oren, M. (1995) Biochemical properties and biological effects of p53. Current Opinion in Genetics & Development, 5, 84-90.
Hahn, G.M., Bagshaw, M.A., Evans, R.G. and Gordon, L.F. (1973) Repair of potentially lethal lesions in x-irradiated, density-inhibited Chinese hamster cells: metabolic effects and hypoxia. Radiation Research, 55, 280-90.
Han, Z., Chatterjee, D., Early, J., Pantazis, P., Hendrickson, E.A. and Wyche, J.H. (1996) Isolation and characterization of an apoptosis-resistant variant of human leukemia HL-60 cells that has switched expression from Bcl-2 to Bcl-xL. Cancer Research, 56, 1621-8.
Heisler, L.E., Evangelou, A., Lew, A.M., Trachtenberg, J., Elsholtz, H.P. and Brown, T.J. (1997) Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Molecular & Cellular Endocrinology, 126, 59-73.
Heyns, W., Drochmans, A., van der Schueren, E. and Verhoeven, G. (1985) Endocrine effects of high-dose ketoconazole therapy in advanced prostatic cancer. Acta Endocrinologica, 110, 276-83.
Ho, Y.S., Wang, Y.J. and Lin, J.K. (1996) Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Molecular Carcinogenesis, 16, 20-31.
Ho, Y.S., Tsai, P.W., Yu, C.F., Liu, H.L, Chen, R.J., and Lin, J.K. (1998) Ketoconazole-Induced Aopoptosis through P53-Dependent Pathway in Human Colorectal and Hepatocellular Carcinoma Cell Lines. Toxicology and Applied Pharmacology, 153, 39-47.
Chen, R.J., Lee, W.S., Liang, Y.C., Lin, J.K, Wang, Y.J., Lin, C.H., Hsieh, J.Y., Chaing, C.C., and Ho, Y.S. (2000) Ketoconazole Induces G0/G1 Arrest in Human Colorectal and Hepatocellular Carcinoma Cell Lines. Toxicology and Applied Pharmacology, 169, 132-141.
Hunter, J.J. and Parslow, T.G. (1996) A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. Journal of Biological Chemistry, 271, 8521-4.
Jan, C. and Tseng, C. (2000) Mechanisms underlying ketoconazole-induced Ca(2+) mobilization in Madin-Darby canine kidney cells. Biochemical Pharmacology, 59, 947-51.
Jenkins, J.R., Rudge, K., Chumakov, P. and Currie, G.A. (1985) The cellular oncogene p53 can be activated by mutagenesis. Nature, 317, 816-8.
Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Research, 51, 6304-11.
Kerr, J.F., Winterford, C.M. and Harmon, B.V. (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer, 73, 2013-26.
Kihana, T., Tsuda, H., Teshima, S., Okada, S., Matsuura, S. and Hirohashi, S. (1992) High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy. Japanese Journal of Cancer Research, 83, 978-84.
Korsmeyer, S.J. (1999) BCL-2 gene family and the regulation of programmed cell death. Cancer Research, 59, 1693s-1700s.
Lundberg, A.S. and Weinberg, R.A. (1999) Control of the cell cycle and apoptosis. European Journal of Cancer, 35, 1886-94.
Mahler, C., Verhelst, J. and Denis, L. (1993) Ketoconazole and liarozole in the treatment of advanced prostatic cancer. Cancer, 71, 1068-73.
Mundle, S., Iftikhar, A., Shetty, V., Dameron, S., Wright-Quinones, V., Marcus, B., Loew, J., Gregory, S. and Raza, A. (1994) Novel in situ double labeling for simultaneous detection of proliferation and apoptosis. Journal of Histochemistry & Cytochemistry, 42, 1533-7.
Nicolle, P., Pontin, A. and Sarembock, L. (1985) High-dose ketoconazole therapy in prostatic cancer. A pilot study. South African Medical Journal, 67, 888-9.
Pont, A., Williams, P.L., Loose, D.S., Feldman, D., Reitz, R.E., Bochra, C. and Stevens, D.A. (1982) Ketoconazole blocks adrenal steroid synthesis. Annals of Internal Medicine, 97, 370-2.
Reed, J.C. (1995a) Bcl-2 family proteins: regulators of chemoresistance in cancer. Toxicology Letters, 82-83, 155-8.
Reed, J.C. (1995b) Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Current Opinion in Oncology, 7, 541-6.
Reed, J.C. (1997) Double identity for proteins of the Bcl-2 family. Nature, 387, 773-6.
Sandau, K., Pfeilschifter, J. and Brune, B. (1997) Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney International, 52, 378-86.
Simbulan-Rosenthal, C.M., Rosenthal, D.S., Hilz, H., Hickey, R., Malkas, L., Applegren, N., Wu, Y., Bers, G. and Smulson, M.E. (1996) The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex. Biochemistry, 35, 11622-33.
Symoens, J. and Cauwenbergh, G. (1983) Ketoconazole, a new step in the management of fungal disease. Progress in Drug Research, 27, 63-84.
Trump, D.L., Havlin, K.H., Messing, E.M., Cummings, K.B., Lange, P.H. and Jordan, V.C. (1989) High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects. Journal of Clinical Oncology, 7, 1093-8.
Tsujimoto, Y., Cossman, J., Jaffe, E. and Croce, C.M. (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science, 228, 1440-3.
van Steenbrugge, G.J., van Uffelen, C.J., Bolt, J. and Schroder, F.H. (1991) The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity. Journal of Steroid Biochemistry & Molecular Biology, 40, 207-14.
Vaux, D.L., Cory, S. and Adams, J.M. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440-2.
Vaux, D.L. and Korsmeyer, S.J. (1999) Cell death in development. Cell, 96, 245-54.
Wood, D.E. and Newcomb, E.W. (1999) Caspase-dependent activation of calpain during drug-induced apoptosis. Journal of Biological Chemistry, 274, 8309-15.
Yonish-Rouach, E. (1996) The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis. Experientia, 52, 1001-7.
Yonish-Rouach, E., Choisy, C., Deguin, V., Breugnot, C. and May, E. (1996) The role of p53 as a transcription factor in the induction of apoptosis. Behring Institute Mitteilungen, 60-71.